International Journal of Endocrinology / 2019 / Article / Tab 4

Research Article

Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism

Table 4

Imaging modalities used for the diagnostic procedure either for primary sites and metastasis.

OesophagusGastricPancreasAppendicealDuodenumJejunum-ileumColonRectumUPTPositive/total exams

Upper endoscopy3/3 (100.0)27/30 (90.0)17/19 (89.5)1/4 (25.0)48/56 (85.7)
Echoendoscopy7/13 (53.8)25/28 (89.3)6/6 (100.0)10/10 (100.0)48/57 (84.2)
Video capsule8/9 (88.9)8/9 (88.9)
Double balloon1/1 (100.0)1/1 (100.0)
Colonoscopy12/33 (36.4)12/12 (100.0)21/22 (95.5)45/67 (67.2)
Entero-CT4/4 (100.0)4/4 (100.0)
Entero-MRI11/11 (100.0)1/1 (100.0)12/12 (100.0)
US scan5/12 (41.7)33/41 (80.5)1/4 (25.0)2/2 (100.0)23/27 (85.2)1/2 (50.0)0/3 (0.0)1/1 (100.0)66/92 (71.7)
CT scan3/3 (100)10/22 (45.5)71/77 (92.2)4/11 (36.4)13/17 (76.5)52/62 (83.9)13/15 (86.7)9/20 (45.0)6/6 (100.0)181/233 (77.7)
MRI0/3 (0.0)38/44 (86.4)1/1 (100.0)5/5 (100.0)11/13 (84.6)2/4 (50.0)4/9 (44.4)2/2 (100.0)63/81 (77.8)
111In-pentetreotide6/17 (35.3)26/36 (72.2)2/6 (33.3)8/12 (66.7)25/30 (83.3)5/8 (62.5)2/9 (22.2)3/3 (100.0)77/121 (63.6)
68Ga-PET-SRP5/12 (41.7)26/31 (83.9)2/5 (40%)1/2 (50.0)32/34 (94.1)2/2 (100.0)5/11 (45.5)2/2 (100.0)75/99 (75.8)
PET-FDG2/2 (100.0)0/5 (0.0)10/17 (58.8)0/1 (0.0)1/1 (100.0)2/4 (50.0)3/5 (60.0)1/1 (100)19/36 (52.8)

Octreoscan®; UPT: unknown primary tumour; CT: computed tomography; MRI: magnetic resonance imaging; PET-FDG: positron emission tomography-(18F) fluorodeoxyglucose.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.